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Abstract
The aim of this study was to identify changes in bovine macrophage gene expression in response to treatment with
Escherichia coli 0157:H7 lipopolysaccharide (LPS), utilizing a human gene microarray. Bovine cDNA from control and LPStreated primary macrophages hybridized to greater than 5644 (79.8%) of the non-control gene targets on a commercially
available microarray containing greater than 7075 targets (Incyte Genomics, St. Louis, MO). Of these target sequences, 44 were
differentially expressed upon exposure to LPS, including 18 genes not previously reported to exist in cattle. These included a
pentaxin-related gene, CASP8, TNF-induced genes, interferon-induced genes, and inhibitors of apoptosis. Using the human
microarray, cDNA from bovine LPS-treated and control macrophages consistently hybridized to targets known to be expressed
constitutively by macrophages, as expected given the predicted cDNA sequence homology. That this human system was
accurately estimating levels of bovine transcripts was further verified by real-time quantitative reverse transcriptase polymerase
chain reaction (RTQ-PCR) using bovine-specific primers. This first report of bovine – human cross-species expression profiling
by microarray hybridization demonstrates the utility of this technique in bovine gene expression and discovery.
Published by Elsevier Ltd.
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expression
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1. Introduction
Identifying genes that affect susceptibility to
mucosal pathogens of livestock will facilitate breeding of disease resistant livestock and also provide
novel insights into the pathogenesis of infectious
disease. Escherichia coli O157:H7 is an important
human pathogen that can be found in the intestines of
cattle, and shed in their feces. We have previously
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used techniques such as RNA fingerprinting by
random arbitrarily-primed polymerase chain reaction
(RAP-PCR) to identify changes in bovine transcript
abundance in response to E. coli O157:H7 lipopolysaccharide (LPS) [1], as well as semi-quantitative
reverse transcriptase polymerase chain reaction (RTPCR) to measure differences in the expression of
bovine cytokines [2 – 5]. These techniques are limited
in that they may not be sensitive enough to identify
subtle changes in gene expression (in the case of RAPPCR) or can only measure expression of a single gene
at one time (RT-PCR). However, the advent of DNA
microarray technology has provided a sensitive tool to
concurrently evaluate expression of thousands of
target sequences [6]. This technology is extremely
useful in understanding the interrelationship of gene
expression involved in the immune system and nonimmune pathways. Using traditional methods, similar
studies would require the daunting task of separately
analyzing each gene in question.
Many growth factors, cytokines, and antibodies
are functionally reactive across species and nucleotide sequence homology among animal species can
be considerable in many genes [7]. Therefore, it is
common for human gene sequences to be used to
design probes for Northern and Southern analyses or
primers for PCR analyses of animal genes [8 – 11].
Based on our past experience utilizing human DNA
sequence to study bovine gene expression [1,2,12],
we hypothesized that the homology between human
and bovine genes was high enough to enable us to
utilize commercially available microarrays manufactured using human gene targets to measure gene
expression in bovine macrophages treated with E. coli
O157:H7 LPS.

2. Materials and methods
2.1. Animals
Approximately, 480 ml of blood were obtained
from each of 44 healthy beef cattle by jugular
venipuncture into 60 cc heparinized syringes. Animals were of both sexes and housed at the U.S. Meat
Animal Research Center (MARC) feedlot in accordance with USDA animal care guidelines.

2.2. Isolation of peripheral blood monocytes
PBMC were isolated from heparinized blood by
density gradient centrifugation over Ficoll-Paque Plus
(Amersham Pharmacia Biotech AB, Uppsala, Sweden), as per the manufacturer’s instructions, and
erythrocytes removed using red blood cell lysing
buffer (Sigma Chemical Co., St. Louis, MO). After
washing with PBS, PBMC were resuspended in 40 ml
of FBS-free Roswell Park Memorial Institute (RPMI)
1640 medium with L -glutamine and dispensed into
four to eight 75-cm2 tissue culture flasks. Monocytes
were isolated by adherence after culturing the cells for
1 h at 37 8C, 5% CO2 followed by washing with PBS
to remove non-adherent cells. Following adherence,
monocyte-derived macrophage cultures were maintained overnight at 37 8C, 5% CO2 in RPMI 1640
medium with L -glutamine, penicillin – streptomycin,
and 5% FBS.
2.3. Purification of LPS
Purified LPS from E. coli O157:H7 was prepared
as previously described [13]. Activity of the LPS was
determined using the E-Toxate limulus amoebocyte
kit (Sigma Chemical Co.), following the manufacturer’s instructions. This assay is sensitive to 0.05 –0.1
endotoxin units per ml. All other reagents used in the
study were determined to be endotoxin-free by the
same method.
2.4. Treatment with LPS
Control cultures were washed with PBS to remove
non-adherent cells and 10 ml of culture medium was
replaced. LPS-treated monocytes were maintained as
described for the controls, however, 10 mg/ml E. coli
O157:H7 LPS was added to the medium. Cells were
cultured for an additional 3 h, washed twice with
10 ml PBS to remove exogenous protein from the cell
cultures, lysed with 1 ml guanidine isothiocyanate,
and frozen within the culture flasks at 2 80 8C until
RNA isolation.
2.5. Isolation of RNA
Total RNA was extracted using phenol-chloroform
as described [14]. Pellets were resuspended in 40 ml
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of diethyl pyrocarbonate (DEPC)-treated water, and
nucleic acid concentration and purity determined by
absorbance at 260 nm. LPS-treated and non-treated
samples were combined into respective pools and
mRNA isolated using OligoTex mRNA isolation
columns (Qiagen, Chatsworth, CA), as per the
manufacturer’s instructions. Samples were precipitated, resuspended in either DEPC water or Tris –
EDTA (TE) at a concentration of 50 ng/ml and
submitted to Incyte Genomics (St. Louis, MO) for
hybridization to a human UniGEM V 1.0 microarray.
2.6. Microarray hybridization and analysis
Microarray hybridization and fluorescent signal
measurements were performed by Incyte Genomics
as previously described [15]. Briefly, human UniGEM V 1.0 microarrays were generated by arraying
PCR amplified sequences onto glass slides. The LPStreated and non-treated bovine macrophage mRNA
pools were reverse-transcribed with 5’-fluorescentlylabeled random 9-mers to generate LPS-treated and
non-treated probe solutions (LPS and control,
respectively). In order to differentiate between the
probe solutions, each was labeled with a different
fluorochrome (LPS and control labeled with Cy3 and
Cy5, respectively). Probe solutions were simultaneously applied to the microarray for hybridization
to target sequences. Hybridization stringency was
proprietary, but identical to that used for human
cDNA.
The microarray was scanned simultaneously with
two independent lasers to detect fluorescence from the
two fluorochromes. The signals were digitized in
order to provide electronic images for visual representation. Incyte GEMtools 2.4 software (Incyte
Pharmaceuticals, Inc., Palo Alto, CA) was used for
image analysis. LPS:control ratios were calculated for
all elements and were used to generate a “balance
coefficient” that was applied in order to balance or
normalize the signals.
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microarray analysis, to verify that hybridization to the
microarray targets was specific and repeatable
(Table 1). Bovine-specific sequences were identified
in the MARC bovine expressed sequence tag libraries
[16] or in GenBank, by using the human sequence
contained in GenBank to search for similar bovine
sequences using a BLAST search (http://www.ncbi.
nlm.nih.gov/BLAST/). RNA samples were treated
with DNA-freee (Ambion, Austin, TX) to ensure that
all DNA had been removed. Assays were assembled
using the Ambion MessageSensorRT kit (Austin, TX)
as per the manufacturer’s instructions. Briefly, a
master mix was prepared for a one step RT-PCR
reaction containing 5.8 ml nuclease-free water, 2.5 ml
10 £ RT-PCR buffer þ SYBR Green I (stock of
10,000 £ diluted 100-fold in nuclease-free water;
Molecular Probes, Inc., Eugene, OR), 2.5 ml 10 £
glycerol, 4 ml dNTP mix (2.5 mM each), 1 ml RNase
inhibitor (10 U/ml), 0.5 ml 50 £ ROX internal
reference (250 mM; Stratagene, La Jolla, CA),
0.2 ml Taq polymerase (5 U/ml), 2.5 ml 10 £ genespecific RT-PCR primer mix (1 mM each of the genespecific forward and reverse primers), 1 ml reverse
transcriptase (1 U/ml), and 5 ml RNA (50 ng). Reactions for each gene were prepared in duplicate for both
LPS-treated and control RNA, and minus-RT controls
and minus-template controls were performed simultaneously. The RTQ-PCR reaction was performed
using the ABI Prism 7700 Sequence Detection System
(Applied Biosystems) in either 8-well strips or 96well plates as follows: Stage 1, 428C for 15 min; Stage
2, 958C for 5 min; Stage 3, 958C for 15 s, 608C for
30 s, and 768C for 50 s. Stage 3 was repeated 39 times
followed by a three-stage melting-curve program to
ensure amplification of a single product: Stage 1, 958C
for 15 s; Stage 2, 608C for 20 s; and Stage 3, a 20-min
ramp to 958C for 15 s with data collected every 7 s.
All PCR reactions were normalized to bovine
ubiquitin-C, and differential expression was determined using the comparative CT method (User
Bulletin #2 ABI Prism 7700 Sequence Detection
System).

2.7. RTQ-PCR verification of hybridization specificity
Bovine-specific primers were designed using
Primer Express version 1.0 (Applied Biosystems,
Foster City, CA) software for all genes that were
significantly altered in expression as measured by

2.8. Determination of homology between human
and bovine sequences
In order to estimate the homology between the
human and bovine gene sequences utilized in this
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Table 1
Oligonucleotidesa for RTQ-PCR analysis of bovine gene expression
BDEe

98

86.8

17.8

GCTGGTTGTCTTACAGCTTCACA
TCTGCCCTTGGCCATCC
AGGATCTTTAACACTCAAGTTTGGC
CATCACAGATGGCCGTTTCC
TCACCCTGGCAGTTAGGAGACT
TCACCCTGGCAGTTAGGAGACT
TCCCATCGCTCCGCTG
CTGCTCGCCATACGTCCG
TAGAGGCAGTTGAGGAGCAGC
TGCATCTCGCAGCGTCTCT
TGTAGCCTTGGCCTCCTCCT
TTTCCTGGTGTAAAAGACAACTGC
AGGAAGGCCAGGTCTCCCT
TTCCTCACTTGCTCTAAGCACTTG
CGCCTTGACCCCACACAT
CCCGGCGCTGAGCA
GCGGCCCACTTGCCA
TCTCCACCAGCAGATCGAGG
ACATCCTTGTGGCGATCCA
TTGCTCCGGGAGATGCC

65
67
77
63
80
80
60
63
62
63
63
73
63
62
63
62
68
63
65
61

3.6
1.7
3.6
2 2.5
1.1
1.1
1.5
1.7
2.1
1.2
2.4
18.7
1.8
1.5
1.5
4.1
1.2
1.8
1.7
1.7

ACAGACAAGGACCACAGGGATG
TTGCTGTGTTGATGCTGCG
ATCCATGGCGAGCTGAACTG
GCCAAGACCCTCAAGCAGC
GACCAGACGATGTGGTCGG
TCCTGCAGCACCTCCCTG
CCCGGTCCATTCACACTCC
GGTCCTCGTTCAAAATCTGTCTTG
GGAGAGATGTGGGAAATGGACT

65
59
63
69
63
62
64
76
86

2.5
1.3
3.8
1.2
1.8
2 1.3
3.8
6.0
2.3

4.3
4.2
3.9
3.7
3.2
3.0
3.0
2.9
2.9
2.7
2.5
2.5
2.4
2.3
2.3
2.3
2.3
2.2
2.2
2.2
2.2
2.2
2.2
2.1
2.1
2.1
2.1
2.1
2.1
2.1

TGGGAGCAAATGCCCTTTC
CTGGACAGAGGAAGCCACATC
TGTTAGCCAGGATGGTATCGATC
CAATGGCAGAGACAAACTTTTCA
TGCTGAGGTTTTTGCCATCA
TGACTCTCCTAGTTGTCCTCAATGA
GCGTCTTGGCTGAGTCAGGT
TGATGATGCAGCCCCCC
GCCTGACCTGCTGCCAATA
TACCAGCCGTTTGATCCTGC
TCCTGCAACTTCTCCCGG
CCATCCACCACCCCCAT

65
73
64
75
71
79
66
60
63
64
60
64

1.6
1.7
2 10.0
2 2.0
2 10.0
2 5.0
2 2.5
2 3.3
2 1.3
2 5.0
2 5.0
2 5.0

2.0
2.0
2.0
2 3.7
2 3.5
2 2.5
2 2.5
2 2.4
2 2.3
2 2.1
2 2.0
2 2.0

Human
accession
number

Bovine
accession
number

% Homology
between
human and
bovine sequencesb

Forward primer

Reverse primer

Amplicon
size (bp)

PTX3

NM_002852

BE664288

87 (468/534)

AAGCACCATGGCATAAAATCTAGTAA

TNFSF2
TNFAIP6
CFLAR
BF
BIRC2
BIRC3
NOS2A
MX1
SERPIND1
IL1RA
ARG2
SCYA20
NFKBIA
CSF3
INDO
TIMP1
IL1A
NFKB2
cig5
ID2
IFIT1
SLC2A3
TNFAIP3
MT1L
CASP4
IFITM1
ISG15
MX2
PTGS2
TOP1

M10988
M31165
AF015450
NM_001710
U37547
U37546
U31511
NM_002462
M58600
X52015
U75667
D86955
AI906005
M17706
NM_002164
AI952703
M28983
S76638
AF026941
AI191485
M24594
AW163231
AI474055
F26407
U25804
BF665518
AI739106
M33883
D28235
M60706

BM255342
BE666586
BF601020
BE845981
BF654068
BF654068
AW654110
NM_173940
CB434316
BE484390
BF652843
AW660024
BI540594
BM256261
BE485813
BI541224
NM_174092
BF652508
CB452670
BG692795
No SEQUENCE
BE899741
CB446530
BE667089
AV618261
NM_174551
NM_174366
NM_173941
AF031698
BE808376

88
91
89
88
80
88
91
81
83
82
89
79
94
89
80
85
82
90
85
89

(338/380)
(491/534)
(215/239)
(469/530)
(399/497)
(440/497)
(504/552)
(1237/1514)
(230/277)
(196/239)
(412/460)
(290/366)
(446/473)
(288/321)
(378/472)
(374/435)
(682/826)
(432/476)
(251/294)
(334/372)

TCTTTATTTATCTTGGCAAAAT
ACTGAGTAA
CCGGTGGTGGGACTCGTAT
GCAGTTAGAGGCAGCCAGAAA
AGTCAGCTCAAGGAGCGGAA
GCTCTGCCAATCGCACCT
CCGGAAGAATAGAATGGCACTT
CCGGAAGAATAGAATGGCACTT
CCACCAACAACGGCAACA
CGCATCTCCGGCCACA
ATACGAGACGCACTGCAGGA
GCTCTTCCTGTTCCGTTCAGA
GCCCTGGACCTCGTTGAA
TCTTGTGGGCTTCACACAGC
CCATGAAGAGAAGGCGCTG
CTTGGCCCTGCCCGA
CACAGCGCCTGGCACAC
GCACATCACCACCTGCAGTT
AGTTGCCCATCCAAAGTTGTTT
TATACCCAGTCCACCTGGCAG
GAAGCGGAACGGTTCGTG
CAGTGAGGTCCGTGAGGAAAA

81
80
84
82
82
76
81
87
96

(424/521)
(78/97)
(202/238)
(474/574)
(317/386)
(362/476)
(1513/1861)
(453/517)
(242/251)

ALAS1
BCL2A1
IFIT4
CD36
FABP5
LGALS3
TGFBI
PGD
TXNIP
LGMN
VIM
NR1H3

AA707391
NM_004049
AF083470
NM_000072
AA931982
AB006780
M77349
U30255
S73591
NM_005606
X56134
NM_005693

AV665498
BI539243
BF776617
AW486990
BF430188
BM258297
BI847961
AW487342
BE589784
BE590231
AV594041
AV610080

83
81
89
*
88
88
90
86
90
84
93
90

(272/324)
(468/571)
(252/281)

TTGGAAGAGCGGTCAGAACC
TGCTAAGCTGGCTGCAAGG
ACCCTCGCCATCCTTTGC
CATATGCCTCCCAGGAATGG
CTTGACGACCACGGTGATCA
ATCAATGTGCCTGCTTTCCAG
CGGAATCATCACCCGGTG
GCACAAATCTGATGTTTGCATTC
TGTGAAGACATTTTTTGCTATAA
TCATTAG
CTTTGCGGAAGACACTGCTG
GCAGATACAGCAACCTGGATCC
GCACTTTGGGAGGCCGA
GCAAGAATGGCGCACCTATT
GGCTCTGCGAAAAGTGGGT
TTGCTTTAGATTTCAAGAGAGGGAA
TCCTGGCCACCAACGG
TTGGCTGGACCCTCAACTATG
AGCGTCCCTGGCTCCAA
TGGAGGACCCTGAGGACG
CGAGGTGGAGCGCGAC
CGGAGGCTCACCAGTTTCA

(394/447)
(345/389)
(501/551)
(416/483)
(456/504)
(438/519)
(532/571)
(616/677)
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Differential
expressioncd

Gene symbol

Sequences listed 50 to 30 .
Percent homology between human and bovine sequences was determined using bl2seq (http://www.ncbi.nlm.nih.gov/blast/bl2seq/bl2.html) with filters “off”. Stars indicate
homology between specific sequences was not significant. The bovine sequences used were selected by homology to other human sequences specific for these genes.
c
Values in gray boxes are not in agreement with microarray results.
d
Differential expression measured using the formula 22DDCt where Ct of the housekeeping gene is subtracted from the Ct of the specific gene from LPS-treated samples (DCts),
subsequently, the Ct of the housekeeping gene is subtracted from the Ct of the specific gene from untreated samples (DCtc). Finally, DCts 2 DCtc ¼ DDCt. In order to report the
reduced differential expression of genes as measured by RTQ-PCR in the same format as the microarray results, these values were further transformed using the formula
21/(22DDCt) ¼ X.
e
Balanced differential expression as determined by microarray analysis.
a

b

1.1
Housekeeping
gene
71
GGAATTTGGGCCAGTGCTC
AA578839
Ubiquitin C

BE668033

*

TCCCTACCTGCATCATGTGC

2 2.0
CAAGGATGGAATCGGCGA
NM_003246
THBS1

AV616902

93 (497/533)

TCCCTGTCATCTGGAATCTTATCA

66

2 2.0
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study, sequences for each gene were aligned using the
bl2seq tool in NCBI BLAST (http://www.ncbi.nlm.
nih.gov/blast/bl2seq/bl2.html). The default settings
were used without the filter in order to analyze the
maximum amount of sequence, and only regions with
significant amounts of homology appeared in the
results.

3. Results
3.1. Hybridization efficiency of bovine cDNA probes
to human microarray target sequences
Probe solutions competed for hybridization to
target sequences on the microarray and hybridization
to a target sequence was scored successful when at
least one of the probe solutions hybridized to that
element. Stringency was maintained at the same level
for cross-species hybridization as was used for human
cDNA. In our study, bovine cDNA probes successfully hybridized to 5644 out of the 7075 non-control
gene targets (79.8%), included on the microarray
(data not shown), demonstrating the utility in crossspecies hybridization as a means to examine bovine
macrophage gene expression.
3.2. mRNA profiles in response to LPS-treatment
of bovine macrophages
Balanced differential expression in monocytederived macrophages was determined by the ratio of
LPS:control signals and balancing these values
against internal control cDNAs present on the
microarray. The values calculated by Incyte Genomics to define significant differential expression were
$ þ 2.0 or # 2 2.0. Analysis of the data with
respect to these cut-off values resulted in 44
(approximately 0.6%) of the target genes being
differentially expressed in response to LPS treatment.
Expression of 34 of these genes was increased, while
10 genes exhibited decreased expression in response
to LPS treatment. Eighteen of these genes have not
previously been reported to exist in cattle (Table 2).
To gain understanding of each of the gene’s role in
response to LPS, we analyzed each responsive gene’s
function using gene ontology components in the
GEMtools 2.4 software package. The majority of
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Table 2
Genes expressed differentially by bovine monocyte-derived macrophages in response to E. coli O157:H7 LPS treatment
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target sequences that were differentially expressed in
response to LPS treatment (66%) are classified as
localized and structural proteins. Other gene classifications that were highly represented in our study were
metabolism, enzyme, signal transduction, growth and
development, and immunity/defense/inflammation
(Table 2).
We were interested in seeing if there were
correlations between gene expression in response to
LPS and overall levels of gene expression. To this
end, we queried the data set for the 25 named target
sequences with the highest LPS or control signal
intensities and compared their differential expression
relative to other genes in the data set. Genes that
exhibited significant differential expression displayed
varying signal intensities from high to low, indicating
that levels of expression did not affect the differential
response to LPS (Table 2), and that the concentration
of RNA utilized was not supersaturating
3.3. Validated expression of selected genes
by RTQ-PCR
Microarray hybridization uses fluorescence to
indirectly measure the level of mRNA transcripts.
Thus, we decided to independently examine the level
of mRNA expression of selected transcripts by a
second method to ensure the cross-species microarray
hybridization results were accurate. RTQ-PCR
bovine-specific primer sets (Table 1) were designed
to amplify and quantitate those genes determined to
be significantly altered in expression by LPS-treatment as measured by microarray analysis. The
average amplicon size was 67 base pairs, and ranged
from 59-98 base pairs (Table 1). Ubiquitin-C, a
constitutively expressed gene, was also analyzed by
RTQ-PCR and used as a normalization control for
each RNA sample. The results of the RTQ-PCR
assays were 90% in agreement with the results of the
microarray hybridization (Table 1).
3.4. Homology between human and bovine sequences
Successful hybridization requires sufficient
sequence homology between the probe solution and
the target genes. Similarly, the quality of an RTQPCR assay is dependent upon the specificity of the
primers for the sequence to be amplified. In order to
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determine the similarity between the human target
sequences used on the microarray and the bovine
sequences used to design RTQ-PCR assays, the
homology between these sequences was estimated
using the NCBI bl2seq tool. The sequence homology
between the two species for all but two genes
analyzed ranged from 76 to 96%, with a mean
homology of 86% (Table 1).

4. Discussion
The purpose of this study was to use a human gene
microarray to identify bovine macrophage genes that
differentially respond to E. coli O157:H7 LPS. Lack
of widely available, high quality, bovine gene
microarrays is a major obstacle in examining global
gene expression responses in bovine cells. It was our
hypothesis that utilizing human gene microarrays
would provide a means to examine bovine cell gene
expression. The stimulation of macrophage gene
expression by LPS is a well-characterized system
that would allow us to evaluate the validity of the
cross-species hybridization technique. In addition,
gene expression resulting from stimulation with LPS
has been shown to overlap with that resulting from
stimulation with whole bacteria [17], and would, thus,
provide insight into the specific responses of bovine
cells to E. coli O157:H7, an important pathogen of
humans.
Macrophages are active cells that elaborate a large
number of cytokines and growth factors required for
antigen processing and presentation, as well as cell
survival. Bacterial LPS triggers the increased
expression of a number of inflammatory cytokines
and factors involved in the bactericidal activity of
macrophages [18,19]. Previously identified constitutively expressed macrophage genes with roles in
coagulation, complement activation, plasma and
matrix function, cell motility, and growth successfully
hybridized with the bovine cDNA [20]. Of the 44
differentially expressed bovine genes identified in this
study, all have been previously identified in human
macrophages or human macrophage-rich tissues
(Table 2). We found the PTX3, MX1, NFKB2,
MT1L, and NFKB1A genes elevated in response to
LPS treatment. All of these genes are known to have a
role in macrophage activation or bactericidal activity

in response to LPS in humans or mice [21 – 26]. In
addition, the macrophage genes TNFa and nitric
oxide synthase 2 (NOS2) exhibited the responses to
LPS described in earlier reports [27 – 30]. Together,
these data demonstrated the utility of using human
gene microarrays for the analysis of bovine macrophage gene expression.
We identified 44 LPS-responsive genes in this
study. It is possible that varying the conditions of
treatment may vary the number of responsive genes
and the level at which they respond. In this study,
monocyte-derived macrophages were treated with
10 mg/ml of E. coli O157:H7 LPS for 1 h. It is entirely
possible that a different list of genes may have been
compiled if the cells were incubated with a different
E. coli strain of LPS, for a different period of time
with the same LPS, or with a different LPS
concentration. Additionally, a number of genes that
were quiescent in mature macrophages and upregulated upon stimulation with LPS may have been
masked due to the artificial stimulation during
adherence of the macrophages to the flasks [31 –33].
Finally, some messages may be highly unstable and
have degraded rapidly prior to isolation. For instance,
in studies using RAP-PCR, different results were
obtained when epithelial cell cultures were treated
with cyclohexamide to stabilize rapidly labile mRNA,
compared to cultures where cyclohexamide was not
used [1].
Variation in results may also be attributable to
differences in age, health status, and/or genetics of the
cattle population selected for macrophage isolation.
Within our study, we controlled for these factors by
pooling RNA from 44 individuals to minimize the
effect of “outlying” animals. In addition, we performed a preliminary microarray experiment using a
pool of RNA from monocyte-derived macrophages
obtained from 35 different cattle and found expression
profiles similar to those described in this experiment
(data not shown). Thus, we feel confidant that we have
identified LPS responsive genes.
As an additional verification that we were specifically measuring differential expression due to LPS
treatment, we compared our data to that of a colleague
studying bovine cell gene expression in a nonmacrophage, non-LPS-treated system using human
microarrays from Incyte Genomics. The 44 genes
differentially expressed in our system were not
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differentially expressed in their studies (Dr Tim
Smith, personal communication). Thus, the results
of our studies cannot be attributed to artifactual
hybridization of bovine cDNA to the human genes on
the array.
Rajeevan et al. have reported that real-time PCR
validated 71% of the genes identified by a human
microarray, suggesting that expression results from
these experiments must be further validated [34]. In
our experiment, RTQ-PCR assays using bovinespecific primers were in greater than 90% agreement
with the results obtained using a human microarray.
This not only provides further validation that the
hybridization of bovine cDNA to human gene
microarray targets is indeed specific, but also that
under the conditions used in our study, was as reliable
as an experiment carried out using cDNA from a
homologous species.
In a study designed to estimate the crosshybridization of similar genes on microarrays,
Evertsz et al. determined that targets containing
greater than 80% identity to the hybridization probe
sequences showed cross-reactivities ranging from 26
to 57%, with percent sequence identity being the
best predictor of hybridization cross-reactivity [15].
They predicted that sufficient homology exists
between species for human microarrays to be used
in cross-species experiments [15]. Out of the 42
genes for which we determined the homology
between the human and bovine sequences, only
two, SCYA20 and ISG15, had identities less than
80% (Table 1). The bovine sequences chosen to
design RTQ-PCR primers for CD36 and ubiquitin C
were selected by searching for bovine sequences
specific for those genes, and not due to homology
with the target sequence on the microarray.
Although these genes share homology in their
entirety, these particular sequences do not. It is
notable that although the results of three of the
RTQ-PCR assays did not agree with those of the
microarray (BF, ISIG15, and CD36), the sequence
homology for these genes ranged from 76 to 89%
(Table 1). However, because the human gene
cDNAs used as targets on the microarray ranged
in size from 500 to 5000 base pairs, our estimates of
homology between the bovine and human sequences
may in reality be greater or less than what actually
existed in these experiments.
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This is the first report of bovine-human crossspecies expression profiling by microarray hybridization. We have identified 44 genes that differentially
respond to E. coli O157:H7 LPS in bovine macrophages. Of these 44 genes, 18 have not previously been
reported in cattle and an additional 17 have not
previously been studied in bovine macrophages. The
pentaxin-related gene has been identified in bovine
cells for the first time and responds dramatically to
LPS treatment. These results demonstrate that the use
of microarrays manufactured with human target
sequences facilitate the analysis of bovine gene
expression. Until such time as bovine species-specific
microarrays become widely available, human microarrays may provide a viable alternative to traditional
assays for screening large numbers of genes for
changes in expression or identification of characterized
human genes as yet unidentified in the bovine genome.
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